T. W. Anderson, Two of Harold Hotelling's contributions to multivariate analysis, Disponible sur, 1990.

A. Baccini and T. P. , SAS numéro 11 Tests statistiques' et 'Exemple Note 2' cours de Travaux pratiques SAS, [en ligne] Disponible sur, 2011.

F. Bertrand and M. Maumy, Quelques tests non paramétriques, Polycopie école doctorale, Disponible sur, 2010.

N. Best, La Lettre de la délégation à la recherche clinique Ile de France, numéro 1, Assistance hôpitaux publique de Paris, Disponible sur, p.16, 2005.

E. Brittain and D. Lin, A comparison of intent-to-treat and per-protocol results in antibiotic non-inferiority trials, Statistics in Medicine, vol.17, issue.1, pp.1-10, 2005.
DOI : 10.1002/sim.1934

L. Brown, T. Cai, and A. Dasgupta, Interval Estimation for a Binomial Proportion, Statistical Science, vol.16, issue.2, pp.101-133, 2001.

C. Burri and R. Brun, Chapiter 13: Human African Trypanosomiasis Manson's Tropical Diseases, pp.1303-1321, 2009.

S. Chabaud and M. Cucherat, L'analyse en intention de traiter et analyse per protocole, Médecine thérapeutique, pp.350-355, 2004.

Y. H. Chan, Quantitative Data ? Parametric & Non-parametric Tests, Singapore Medical Journal, issue.8, pp.44-391, 2003.

C. Montpellier, Recherche clinique : La réglementation [en ligne] Disponible sur, 2006.

D. Agostino, R. Stephens, and M. A. , Goodness-of-Fit Techniques, p.104, 1986.

D. Agostino, R. Massaro, J. Sullivan, and L. , Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics, Statistics in Medicine, vol.13, issue.2, pp.169-186, 2003.
DOI : 10.1002/sim.1425

R. Disantostephano and K. Muller, A comparison of power approximations for satterthwaite's test, Communications in Statistics - Simulation and Computation, vol.1, issue.3, pp.583-593, 1995.
DOI : 10.2307/2289941

. Dndi, Drugs for Neglected Diseases Initiative) NECT Combinaison Thérapeutique de Nifurtimox et d'Eflornithine. [en ligne]. Disponible sur : http://www.dfid.gov.uk/R4D, DNDI/NECT_press_pack_%28French%29.pdf (consulté le 05.05, 2011.

. Dndi, Maladie du sommeil : La trypanosomiase humaine africaine (THA) , DNDi Newsletter, Disponible sur, 2008.

. Dndi, NECT -combinaison thérapeutique contre la maladie du sommeil -inclus dans la liste des médicaments essentiels de l'OMS, Press Releases, Disponible sur, 2009.

S. Ellenberg and R. Temple, Placebo-Contolled Trials and Active-Control Trials in the evaluation of new treatments, Annals of Internal Medecine, vol.133, issue.6, pp.474-475, 2000.

A. Garrett, Therapeutic equivalence: fallacies and falsification, Statistics in Medicine, vol.14, issue.5, pp.741-762, 2003.
DOI : 10.1002/sim.1360

S. Geffray, 2010) d'analyse de survie GFMgroup (Groupe Français des Myélodisplasie) Qu'est-ce qu'un essai clinique, Disponible sur, 2005.

D. Grau, Tests du khi-deux, Disponible sur, 2011.

J. Hervy, photo Glossina palpalis, mouche tsé-tsé qui transmet la maladie du sommeil, [en ligne] Disponible sur : http://www.futura-sciences.com/fr/doc/t/medecine-1/d/maladie-du- sommeil-terrible-fleau-pour-lafrique_664/c3, p.4, 2011.

J. Hummel and S. Wiseman, Non-inferiority Studies with Binary Endpoint: Analysis with Adjustement for Covariates, PSI/EFSPI Annual Conference, Disponible sur, 2008.

J. Johnson and D. Fitts, Statistical analysis plans principles and practice Disponible sur: http://www.sctweb.org/presentations, 2007.

C. Le, S. Les-macros, and D. Ingénierie-mathématique-du-cnam, Disponible sur : http://ww1.cnam.fr/maths, SAS_macros.pdf, 2011.

M. Meddra, Medical Dictionary for Regulatory Activities Maintenance and Support Services Organization, Disponible sur

. Novartis, Essais cliniques, Disponible sur

. Omnilogie and . L-'échelle-de-glasgow, ou comment savoir si une personne est dans le coma, [en ligne] Disponible sur : http://omnilogie Trypanosomiase humaine africaine (maladie de sommeil) : mise à jour épidémiologique, L%27%C3%A9chelle_de_Glasgow_ou_comment_savoir_si_une_perso nne_est_dans_le_coma 38. OMS (Organisation Mondiale de la Santé, pp.69-80, 2006.

G. Priotto, C. Fogg, M. Balasegaram, O. Erphas, and A. Louga, Three Drug Combinations for Late-Stage Trypanosoma brucei gambiense Sleeping Sickness: A Randomized Clinical Trial in Uganda, PLoS Clinical Trials, vol.2, issue.8, 2006.
DOI : 10.1371/journal.pctr.0010039.sd005

G. Priotto, S. Kasparian, and W. Mutombo, Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial, The Lancet, vol.374, issue.9683, pp.56-64, 2009.
DOI : 10.1016/S0140-6736(09)61117-X

V. Rousson and B. Seifert, A Mixed Approach for Proving Non-Inferiority in Clinical Trials with Binary Endpoints, Biometrical Journal, vol.47, issue.2, pp.190-204, 2008.
DOI : 10.1002/bimj.200710410

S. Support, Example 49.2 Enhanced Survival Plot and Multiple-Comparison Adjustments [en ligne] Disponible sur: http://support.sas.com/documentation, 2011.

S. Snapinn, Noninferiority trials, Current Controlled Trials in Cardiovascular Medicine, vol.1, issue.1, pp.19-21, 2000.
DOI : 10.1186/CVM-1-1-019

N. Schenker and J. Gentleman, On Judging the Significance of Differences by Examining the Overlap Between Confidence Intervals, The American Statistician, p.55, 2001.

J. Shostak, SAS Programming in the Pharmaceutical Industry, 1 re édition, 2005.

M. A. Stephens, EDF Statistics for Goodness of Fit and Some Comparisons, Journal of the American Statistical Association, vol.10, issue.1, pp.69-730, 1974.
DOI : 10.1111/j.1467-9574.1967.tb00548.x

J. Swanepoel and F. Van-graan, Goodness-of-fit tests based on estimated expectations of probability integral transformed order statistics, Annals of the Institute of Statistical Mathematics, vol.54, issue.3, pp.531-542, 2002.
DOI : 10.1023/A:1022407026245

R. Temple and S. Ellenberg, Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 1: Ethical and Scientific Issues, Annals of Internal Medicine, vol.133, issue.6, pp.474-475, 2000.
DOI : 10.7326/0003-4819-133-6-200009190-00014

P. L. Tien, T. Lin, and M. Mcgranaghan, Some Tips and Examples for Using SAS® PROC TABULATE, [en ligne]. Disponible sur : http://www2.sas.com/proceedings, 2011.

D. Tu, On the use of the ratio or the odds ratio of cure rates in therapeutic equivalence clinical trials with binary endpoints, Journal of Biopharmaceutical Statistics, vol.43, issue.2, pp.263-282, 1998.
DOI : 10.1111/j.1469-1809.1955.tb01285.x

G. Tunes-da-silva, B. Logan, and J. Klein, Methods for Equivalence and Noninferiority Testing, Biology of Blood and Marrow Transplantation, vol.15, issue.1, pp.120-127, 2008.
DOI : 10.1016/j.bbmt.2008.10.004

H. Wang, S. C. Chow, L. , and G. , ON SAMPLE SIZE CALCULATION BASED ON ODDS RATIO IN CLINICAL TRIALS, Journal of Biopharmaceutical Statistics, vol.25, issue.4, pp.471-483, 2002.
DOI : 10.1080/10543409808835238

S. Wellek, Statistical Methods for the Analysis of Two-Arm Non-inferiority Trials with Binary Outcomes, Biometrical Journal, vol.41, issue.1, pp.48-61, 2005.
DOI : 10.1002/bimj.200410090

R. Wolfe and J. Hanley, If we're so different, why do we keep overlapping? When 1 plus1 doesn't make 2, Canadian Medical Association Journal, vol.166, issue.1, pp.65-66, 2002.

H. Xiaomin and W. Shwu-jen, Confidence Intervals for the Binomial Proportion with Zero Frequency, ICON Clinical Research, 2009.

Y. Zhang and J. , Confidence interval and the Student's t-test, [en ligne]. Disponible sur, 2006.

S. Analysis and .. , 20 a. Clinical adverse events, Vital signs, vol.2121